Financial reports
Current reports
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
2 May 24
8-K
Mangoceuticals Acquires Global Patent Portfolio
25 Apr 24
8-K
Entry into a Material Definitive Agreement
11 Apr 24
8-K
Departure of Directors or Certain Officers
26 Mar 24
8-K
Other Events
25 Jan 24
8-K
Other Events
23 Jan 24
8-K
Departure of Directors or Certain Officers
29 Dec 23
8-K
Mangoceuticals, Inc. Announces Pricing of $1,200,000 Public Offering
19 Dec 23
8-K
Entry into a Material Definitive Agreement
11 Dec 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7 Nov 23
Registration and prospectus
S-1
IPO registration
23 Apr 24
POS AM
Prospectus update (post-effective amendment)
18 Dec 23
POS AM
Prospectus update (post-effective amendment)
15 Dec 23
S-1/A
IPO registration (amended)
12 Dec 23
S-1
IPO registration
11 Dec 23
DRS
Draft registration statement
24 Nov 23
S-8
Registration of securities for employees
18 Apr 23
424B4
Prospectus supplement with pricing info
21 Mar 23
424B4
Prospectus supplement with pricing info
21 Mar 23
S-1/A
IPO registration (amended)
28 Feb 23
Other
EFFECT
Notice of effectiveness
20 Dec 23
EFFECT
Notice of effectiveness
15 Dec 23
CORRESP
Correspondence with SEC
11 Dec 23
CORRESP
Correspondence with SEC
11 Dec 23
CORRESP
Correspondence with SEC
11 Dec 23
CORRESP
Correspondence with SEC
11 Dec 23
UPLOAD
Letter from SEC
30 Nov 23
SEC STAFF LETTER
SEC staff letter
29 Mar 23
CERT
Certification of approval for exchange listing
21 Mar 23
EFFECT
Notice of effectiveness
21 Mar 23
Ownership
4
Jacob D. Cohen
29 Dec 23
SC 13D/A
Cohen Jacob D.
29 Dec 23
4
EUGENE M JOHNSTON
4 Oct 23
4
Amanda Elizabeth Hammer
4 May 23
3
Amanda Elizabeth Hammer
4 May 23
SC 13D
Cohen Jacob D.
3 May 23
4
Jacob D. Cohen
2 May 23
3
Alex P. Hamilton
21 Mar 23
3
Jonathan Arango
20 Mar 23
3
EUGENE M JOHNSTON
20 Mar 23